Skip to main content

Single-Photon-Emitting Radiopharmaceuticals

  • Chapter
  • First Online:
Nuclear Medicine Textbook

Abstract

A radiopharmaceutical consists of a biochemical core linked to a radionuclide emitting radioactive signal that can be detected from outside the body providing funcional information. Imaging with singlephoton-emitting radionuclides (radioisotopes of elements) produces both planar images and single-photon emission computed tomography (SPECT) using a gamma camera. Radiopharmaceuticals labeled with positron-emitting radionuclides are used for positron emission tomography imaging (as described in Chap. 3 of this book “Positron-emitting radiopharmaceuticals”), while radiopharmaceuticals emitting predominantly β or α-particles are used for therapeutic purposes (as described in Chap. 4 of this book). The diagnostic information provided by scintigraphic images derives from the specific distribution of a radiopharmaceutical within the body. The chemical and physical characteristics of a radiopharmaceutical are the main factors determining its accumulation and retention in normal and diseased tissues of the organism. The radionuclides most frequently used for diagnostic applications in conventional nuclear medicine are the isotopes of technetium, iodine, indium, gallium, and thallium. This chapter classifies radiopharmaceuticals according to radionuclide used for labeling and to the main mechanism(s) of tissue localization responsible for the specific distribution properties of the imaging agent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    DOTA = tetraazacyclododecane-1,4,7,10-tetraacetic acid

References

  1. Lassmann MS, Treves T, For the EANM/SNMMI Paediatric Dosage Harmonization Working Group. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines. Eur J Nucl Med Mol Imaging. 2014;41:1636. Accessible at: http://www.eanm.org/publications/dosage-card/.

    Article  Google Scholar 

  2. Williams JG. Pertechnetate and the stomach. A continuing controversy. J Nucl Med. 1983;24:63–6.

    Google Scholar 

  3. ICRP. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. ICRP publication 128. Ann ICRP. 2015;44(2S):7.

    Google Scholar 

  4. Eckelman W, Richards P. Instant 99mTc-DTPA. J Nucl Med. 1970;11:761.

    CAS  PubMed  Google Scholar 

  5. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med. 1986;27:111–6.

    CAS  PubMed  Google Scholar 

  6. Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, Kunikowska J, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2014;41:1259–60.

    Article  Google Scholar 

  7. Fazzi P, Borsò E, Albertelli R, Mariani G, Giuntini C. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction. Q J Nucl Med Mol Imaging. 2009;53:428–36.

    CAS  PubMed  Google Scholar 

  8. Abrams MJ, Davison A, Jones AG, et al. Synthesis and characterization of hexakis (alkylisocyanide) and hexakis (arylisocyanide complexes of Technetium (I)). Inorg Chem. 1983;22:2798.

    Article  CAS  Google Scholar 

  9. Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99mTc-Sestamibi – a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791–4.

    Article  CAS  Google Scholar 

  10. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 1994;178:49–7.

    Google Scholar 

  11. Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med. 1993;34:222.

    CAS  PubMed  Google Scholar 

  12. ICRP. Radiation dose to patients from radiopharmaceuticals. ICRP publication 53. Ann ICRP. 1988;18(1-4):149.

    Google Scholar 

  13. Nickers NM, Collier B. Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman LS, Gilman A, editors. The pharmacological basis of therapeutics. 5th ed. New York, NY: Macmillan Publishing Co; 1975. p. 553–64.

    Google Scholar 

  14. Short JH, Darby TD. Sympathetic nervous system blocking agents. III. Derivatives of benzylguanidine. J Med Chem. 1967;10:833–40.

    Google Scholar 

  15. Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with[131I]Iodobenzylguanidine. J Nucl Med. 1980;21:349–53.

    CAS  PubMed  Google Scholar 

  16. Edwards CL, Hayes RL. Tumor scanning with 67Ga citrate. J Nucl Med. 1969;10:103–5.

    CAS  PubMed  Google Scholar 

  17. Kropp J, Buhr W, Bockisch A, Grünwald F, Ruhlmann J, Hotze A, Biersack HJ. Inhalation scintigraphy of the lung using the new ultrafine aerosol Technegas. Nuklearmedizin. 1989;28:46.

    Google Scholar 

  18. Knipping HW, Bolt W, Venrath H, Valentin H, Ludes H, Endler P. A new method of heart and lung function testing, the regional functional analysis in the lung and heart clinic by the radioactive noble gas xenon 133 (isotope thoracography). Dtsch Med Wochenschr. 1955;80:1146–7.

    CAS  PubMed  Google Scholar 

Suggested Readings

  • Ell PJ, Gambhir SS, editors. Nuclear medicine in clinical diagnosis and treatment. 3rd ed. New York, NY: Churchill Livingston; 2004.

    Google Scholar 

  • Herbert JC, Eckelman WC, Neumann RD, editors. Nuclear medicine – diagnosis and therapy. New York, NY: Thieme Medical Publishers; 1996.

    Google Scholar 

  • IAEA. Good practice for introducing radiopharmaceuticals for clinical use. Vienna: International Atomic Energy Agency (IAEA; 2015.

    Google Scholar 

  • IAEA. Operational guidance on hospital radiopharmacy. Vienna: International Atomic Energy Agency (IAEA); 2008.

    Google Scholar 

  • IAEA. Radiopharmaceuticals for sentinel lymph node detection: status and trends. Vienna: International Atomic Energy Agency (IAEA); 2015.

    Google Scholar 

  • IAEA. Technetium-99m radiopharmaceuticals: status and trends. Vienna: International Atomic Energy Agency (IAEA); 2010.

    Google Scholar 

  • Kowalsky RJ, Falen SW, editors. Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 3rd ed. Washington, DC: American Pharmacists Association; 2011.

    Google Scholar 

  • Owunwanne A, Patel M, Sadek S, editors. The handbook of radiopharmaceuticals. New York, NY: Springer; 1995.

    Google Scholar 

  • Schwochau K, editor. Technetium: chemistry and radiopharmaceuticals. Hoboken, NJ: Wiley; 2000.

    Google Scholar 

  • Subramanian G, Rhodes BA, Cooper JF, Sodd VJ. Radiopharmaceuticals. New York, NY: Society of Nuclear Medicine; 1975.

    Google Scholar 

  • Theobald T, editor. Sampson’s textbook of radiopharmacy. 4th ed. London: Pharmaceutical Press; 2010.

    Google Scholar 

  • Vallabhajosula S. Molecular imaging – radiopharmaceuticals for PET and SPECT. Berlin: Springer; 2009.

    Google Scholar 

  • Welch MJ, Redvanly CS, editors. Handbook of radiopharmaceuticals: radiochemistry and applications. Hoboken, NJ: Wiley; 2003.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Federica Orsini .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Orsini, F., Puta, E., Guidoccio, F., Mariani, G. (2019). Single-Photon-Emitting Radiopharmaceuticals. In: Volterrani, D., Erba, P.A., Carrió, I., Strauss, H.W., Mariani, G. (eds) Nuclear Medicine Textbook. Springer, Cham. https://doi.org/10.1007/978-3-319-95564-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95564-3_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95563-6

  • Online ISBN: 978-3-319-95564-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics